» Authors » Guido Jenster

Guido Jenster

Explore the profile of Guido Jenster including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 125
Citations 11214
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gurrieri E, Carradori G, Roccuzzo M, Pancher M, Peroni D, Belli R, et al.
J Biomed Sci . 2024 Oct; 31(1):92. PMID: 39402557
Background: Extracellular vesicles (EVs) are cell-secreted particles conceived as natural vehicles for intercellular communication. The capacity to entrap heterogeneous molecular cargoes and target specific cell populations through EV functionalization promises...
2.
Islam M, Dhondt B, Syed P, Khan M, Gidwani K, Webber J, et al.
J Extracell Biol . 2024 Jun; 1(10):e64. PMID: 38939212
Urinary extracellular vesicles (uEVs) are enriched with glycosylated proteins which have been extensively studied as putative biomarkers of urological cancers. Here, we characterized the glycosylation and integrin profile of EVs...
3.
Basso M, Gori A, Nardella C, Palviainen M, Holcar M, Sotiropoulos I, et al.
J Extracell Biol . 2024 Feb; 3(1). PMID: 38405579
The 'QuantitatEVs: multiscale analyses, from bulk to single vesicle' workshop aimed to discuss quantitative strategies and harmonized wet and computational approaches toward the comprehensive analysis of extracellular vesicles (EVs) from...
4.
Mehralivand S, Thomas C, Puhr M, Claessens F, van de Merbel A, Dubrovska A, et al.
J Transl Med . 2024 Jan; 22(1):71. PMID: 38238739
The androgen receptor (AR) is a crucial player in various aspects of male reproduction and has been associated with the development and progression of prostate cancer (PCa). Therefore, the protein...
5.
Wang A, Shen J, Rodriguez A, Saunders E, Chen F, Janivara R, et al.
Nat Genet . 2023 Nov; 55(12):2065-2074. PMID: 37945903
The transferability and clinical value of genetic risk scores (GRSs) across populations remain limited due to an imbalance in genetic studies across ancestrally diverse populations. Here we conducted a multi-ancestry...
6.
Barros-Silva D, Tsui J, Jeronimo C, Jenster G, Martens-Uzunova E
Biotechniques . 2023 Jun; 74(5):225-235. PMID: 37272338
Ribose 2'O-methylation (Nm, ribomethylation) is the most abundant RNA modification present in rRNA. It has been shown that alterations in ribosomal 2'O-methylation at individual Nm sites likely reflect regulated cellular...
7.
Isebia K, Lolkema M, Jenster G, de Wit R, Martens J, van Riet J
Int J Mol Sci . 2023 Mar; 24(6). PMID: 36983083
Treatment-induced AR alterations, including AR alternative splice variants (AR-Vs), have been extensively linked to harboring roles in primary and acquired resistance to conventional and next-generation hormonal therapies in prostate cancer...
8.
Mehra N, Kloots I, Vlaming M, Aluwini S, Dewulf E, Oprea-Lager D, et al.
Eur Urol Open Sci . 2023 Mar; 49:23-31. PMID: 36874601
Background: Germline and tumour genetic testing in prostate cancer (PCa) is becoming more broadly accepted, but testing indications and clinical consequences for carriers in each disease stage are not yet...
9.
Severson T, Zhu Y, Prekovic S, Schuurman K, Nguyen H, Brown L, et al.
medRxiv . 2023 Mar; PMID: 36865297
Androgen Receptor (AR) signaling inhibitors, including enzalutamide, are treatment options for patients with metastatic castration-resistant prostate cancer (mCRPC), but resistance inevitably develops. Using metastatic samples from a prospective phase II...
10.
Wu L, Woud W, Baan C, Hesselink D, van der Pol E, Jenster G, et al.
Nanomedicine . 2022 Dec; 48:102638. PMID: 36549551
Urinary extracellular vesicles (uEVs) are promising biomarkers for various diseases. However, many tools measuring uEVs rely on time-consuming uEV isolation methods, which could induce sample bias. This study demonstrates the...